A detailed history of Round Angle Advisors LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Round Angle Advisors LLC holds 195,875 shares of OCUL stock, worth $1.59 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares
195,875
Previous 198,456 1.3%
Holding current value
$1.59 Million
Previous $1.69 Billion 15.28%
% of portfolio
1.32%
Previous 1.61%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 25, 2025

SELL
$5.93 - $9.08 $15,305 - $23,435
-2,581 Reduced 1.3%
195,875 $1.44 Billion
Q4 2024

Jan 16, 2025

BUY
$8.33 - $11.47 $1.65 Million - $2.28 Million
198,456 New
198,456 $1.69 Billion

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $625M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Round Angle Advisors LLC Portfolio

Follow Round Angle Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Round Angle Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Round Angle Advisors LLC with notifications on news.